医药制造业上市公司财务绩效综合评价——基于主成分分析法的实证研究毕业论文.doc

毕业论文 （20_ _届） 医药制造业上市公司财务绩效综合评价——基于主成分分析法的实证研究 摘 要 上市公司的财务绩效从根本上决定了资源的合理配置及市场的有序竞争。本文以2007～2009年沪、深两市55家医药制造业上市公司的财务数据和市场数据为样本，从偿债能力、盈利能力、发展能力、营运能力等四个方面选取14项指标，首先进行描述性统计分析，然后运用主成分分析法，构建了基于医药制造业上市公司财务数据的业绩评价指标体系，实证检验财务绩效对医药制造业上市公司的影响。通过分析得出以下结论：（1）主成分分析法的评价结果基本上反映了各医药制造业上市公司的现实状况。（2）医药制造业上市公司财务绩效评价按重要性依次为公司的偿债能力、盈利能力、发展能力、营运能力这四个方面。仍需做进一步研究，本文未对非财务绩效评价进行探讨，而且主成分累计解释比例与85%的经验值存在一定的差距。 关键词：Abstract Financial performance of listed companies to fundamentally determine the rational allocation of resources and orderly market competition. In this paper, 2007 ~ 2009 Shanghai and Shenzhen listed companies, 55 pharmaceutical industry financial data and market data for the samples from the solvency, profitability, capacity development, operational capacity of 14 indicators in four areas selected, the first descriptive statistical analysis, using principal component analysis and then constructed based on financial data of listed companies pharmaceutical manufacturing performance evaluation index system, empirical test of financial performance of listed companies on the impact of pharmaceutical industry. Obtained by analyzing the following results: (1) Principal component analysis of the evaluation results basically reflects the medical reality of listed manufacturing companies. (2) Medical evaluation of financial performance of listed manufacturing companies in order of importance for the companys solvency, profitability, capacity development, operational capacity of these four aspects. Still need to do further research, this article did not discuss non-financial performance evaluation, and interpretation of principal component ratio and 85% of the cumulative experience of value there is a certain gap. Keywords: pharmaceutical manufacturing listed company; financial performance; principal component analysis 目 录1 引言 1 1.1 研究背景 1 1.2 研究目的及意义 1 1.2.1 研究目的 1 1.2.2 研究意义 2 1.3 研究思路和框架 2 2 上市公司财务绩效评价概论 4 2.1 绩效的基本概念 4 2.2 绩效评价 4 2.3 财务绩效评价 4 3 医药制造业上市公司财务绩效评价指标体系的构建 6 3.1 细分行业进行绩